247 related articles for article (PubMed ID: 8958213)
1. In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor.
Cao Y; Linden P; Shima D; Browne F; Folkman J
J Clin Invest; 1996 Dec; 98(11):2507-11. PubMed ID: 8958213
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and physiological activity of heterodimers comprising different splice forms of vascular endothelial growth factor and placenta growth factor.
Birkenhäger R; Schneppe B; Röckl W; Wilting J; Weich HA; McCarthy JE
Biochem J; 1996 Jun; 316 ( Pt 3)(Pt 3):703-7. PubMed ID: 8670141
[TBL] [Abstract][Full Text] [Related]
3. Neovascularization in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta-derived growth factor.
Viglietto G; Romano A; Maglione D; Rambaldi M; Paoletti I; Lago CT; Califano D; Monaco C; Mineo A; Santelli G; Manzo G; Botti G; Chiappetta G; Persico MG
Oncogene; 1996 Aug; 13(3):577-87. PubMed ID: 8760299
[TBL] [Abstract][Full Text] [Related]
4. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.
Cao Y; Chen H; Zhou L; Chiang MK; Anand-Apte B; Weatherbee JA; Wang Y; Fang F; Flanagan JG; Tsang ML
J Biol Chem; 1996 Feb; 271(6):3154-62. PubMed ID: 8621715
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction.
Khaliq A; Dunk C; Jiang J; Shams M; Li XF; Acevedo C; Weich H; Whittle M; Ahmed A
Lab Invest; 1999 Feb; 79(2):151-70. PubMed ID: 10068204
[TBL] [Abstract][Full Text] [Related]
6. Automated evaluation of angiogenic effects mediated by VEGF and PlGF homo- and heterodimers.
Kurz H; Wilting J; Sandau K; Christ B
Microvasc Res; 1998 Jan; 55(1):92-102. PubMed ID: 9473412
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of a naturally occurring vascular endothelial growth factor.placenta growth factor heterodimer.
DiSalvo J; Bayne ML; Conn G; Kwok PW; Trivedi PG; Soderman DD; Palisi TM; Sullivan KA; Thomas KA
J Biol Chem; 1995 Mar; 270(13):7717-23. PubMed ID: 7706320
[TBL] [Abstract][Full Text] [Related]
8. Effects of angiogenic growth factor combinations on retinal endothelial cells.
Castellon R; Hamdi HK; Sacerio I; Aoki AM; Kenney MC; Ljubimov AV
Exp Eye Res; 2002 Apr; 74(4):523-35. PubMed ID: 12076096
[TBL] [Abstract][Full Text] [Related]
9. Placenta growth factor (PlGF) mRNA expression in brain tumors.
Nomura M; Yamagishi S; Harada S; Yamashima T; Yamashita J; Yamamoto H
J Neurooncol; 1998 Nov; 40(2):123-30. PubMed ID: 9892094
[TBL] [Abstract][Full Text] [Related]
10. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen--a review.
Ahmed A; Dunk C; Ahmad S; Khaliq A
Placenta; 2000; 21 Suppl A():S16-24. PubMed ID: 10831117
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia and vascular endothelial growth factor stimulate angiogenic integrin expression in bovine retinal microvascular endothelial cells.
Suzuma K; Takagi H; Otani A; Honda Y
Invest Ophthalmol Vis Sci; 1998 May; 39(6):1028-35. PubMed ID: 9579483
[TBL] [Abstract][Full Text] [Related]
12. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis.
Takahashi A; Sasaki H; Kim SJ; Tobisu K; Kakizoe T; Tsukamoto T; Kumamoto Y; Sugimura T; Terada M
Cancer Res; 1994 Aug; 54(15):4233-7. PubMed ID: 7518352
[TBL] [Abstract][Full Text] [Related]
13. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.
Sawano A; Takahashi T; Yamaguchi S; Aonuma M; Shibuya M
Cell Growth Differ; 1996 Feb; 7(2):213-21. PubMed ID: 8822205
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.
Viglietto G; Romano A; Manzo G; Chiappetta G; Paoletti I; Califano D; Galati MG; Mauriello V; Bruni P; Lago CT; Fusco A; Persico MG
Oncogene; 1997 Nov; 15(22):2687-98. PubMed ID: 9400995
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor.
Monsky WL; Fukumura D; Gohongi T; Ancukiewcz M; Weich HA; Torchilin VP; Yuan F; Jain RK
Cancer Res; 1999 Aug; 59(16):4129-35. PubMed ID: 10463618
[TBL] [Abstract][Full Text] [Related]
16. The basic residues of placenta growth factor type 2 retrieve sequestered angiogenic factors into a soluble form: implications for tumor angiogenesis.
Barillari G; Albonici L; Franzese O; Modesti A; Liberati F; Barillari P; Ensoli B; Manzari V; Santeusanio G
Am J Pathol; 1998 May; 152(5):1161-6. PubMed ID: 9588884
[TBL] [Abstract][Full Text] [Related]
17. Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen.
Shima DT; Adamis AP; Ferrara N; Yeo KT; Yeo TK; Allende R; Folkman J; D'Amore PA
Mol Med; 1995 Jan; 1(2):182-93. PubMed ID: 8529097
[TBL] [Abstract][Full Text] [Related]
18. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic.
Ziche M; Maglione D; Ribatti D; Morbidelli L; Lago CT; Battisti M; Paoletti I; Barra A; Tucci M; Parise G; Vincenti V; Granger HJ; Viglietto G; Persico MG
Lab Invest; 1997 Apr; 76(4):517-31. PubMed ID: 9111514
[TBL] [Abstract][Full Text] [Related]
19. Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor.
Lacal PM; Failla CM; Pagani E; Odorisio T; Schietroma C; Falcinelli S; Zambruno G; D'Atri S
J Invest Dermatol; 2000 Dec; 115(6):1000-7. PubMed ID: 11121133
[TBL] [Abstract][Full Text] [Related]
20. Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents.
Gleadle JM; Ebert BL; Firth JD; Ratcliffe PJ
Am J Physiol; 1995 Jun; 268(6 Pt 1):C1362-8. PubMed ID: 7541940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
